$VICR

Davies Philip D sold $64K of VICR

Davies Philip D (VP Global Sales & Marketing) sold 200 shares of VICOR CORP (VICR) at $321.92 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Jun 2, 2026, 2:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 2:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because the sale is pre-planned, it is generally treated as routine rather than a fundamental catalyst; the main tradable element is short-lived sentiment/positioning around insider headlines.

02

Market read

Insider selling headline for VICR, but the 10b5-1 structure and small size suggest limited fundamental impact.

03

What to watch

The disclosure doesn’t indicate motivation; the key is whether there are repeated transactions across multiple insiders or plan changes.

Relevance 3/10Novelty 2/10Timing: Filed today (2026-06-02) for a sale executed 2026-06-01

Background

This is an SEC Form 4 insider transaction disclosure (officer/director) for Vicor, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

SEC Form 4 shows VP Global Sales & Marketing Philip D. Davies sold 200 shares of Vicor on 2026-06-01 under a 10b5-1 plan.

Expected impact

Likely minimal price impact; any move would be noise around insider-flow headlines.

Evidence & confidence

The filing is an ownership-change disclosure with a pre-arranged 10b5-1 plan and a relatively small share count/value versus typical daily liquidity.

Market effects

No clear sector read-through from a single, small 10b5-1 sale.

None.

None.

Counterpoint

Even 10b5-1 sales can coincide with internal views on near-term risk; traders may still watch for follow-on sales/buys.

Key entities

  • VICOR CORP

    Subject of the SEC Form 4 insider transaction disclosure.

  • Davies Philip D

    VP Global Sales & Marketing who sold 200 shares on 2026-06-01 under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: